CompletedEarly Phase 1NCT01050777

Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tehran University of Medical Sciences
Principal Investigator
Masud Maleki, MD
Mashhad University of Medical Sciences, Mashhad, Iran
Intervention
Liposomal meglumine antimoniate (Glucantime)(drug)
Enrollment
30 target
Eligibility
12-60 years · All sexes
Timeline
2011 – 2012

Study locations (1)

Collaborators

Mashhad University of Medical Sciences · Center for Research and Training in Skin Diseases and Leprosy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01050777 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials